Home »

What are beta cell therapies, and do they offer hope for a cure for type 1 diabetes?
Clinical trials in beta cell replacement are creating a buzz among the diabetes community. We explain what beta cell therapies are, how close they could be to becoming a potential treatment option,…

The Type 1 Diabetes Grand Challenge makes waves at DUKPC
The Type 1 Diabetes Grand Challenge took centre stage at this year’s Diabetes UK Professional Conference, uniting researchers and people affected by type 1 diabetes to share their expertise and cel…
From discovery to innovation: 103 years of insulin progress
11 January 2025 marked exactly 103 years since insulin was first given to a person with type 1 diabetes, a 14-year-old boy called Leonard Thompson. The history of insulin is one of scientific break…
New funding available to boost beta cell research in the UK
We’re launching a new funding call to address the limited availability of stem cell-derived beta cells for research purposes.

Gaining pace towards a cure – a round-up of 2024
The global quest to create better treatments and find ways to prevent and cure type 1 diabetes continued to gather pace in 2024. Here, we round-up the highlights of the year.

The Grand Challenge community – “Work differently, work collaboratively, work swiftly”
In November, we hosted our Beta Cell Therapy and Root Causes Symposium, uniting the rapidly growing Type 1 Diabetes Grand Challenge community. We hear from Mirjam Eiswirth, who lives with type 1 di…

Four innovative projects receive funding from the Type 1 Diabetes Grand Challenge
We’re investing over £2 million into four new research projects exploring creative approaches to improve beta cell therapies and tackle immune system dysfunction in type 1 diabetes.
New ‘smart insulin’ marks promising step forward in type 1 diabetes treatment
Researchers have developed a ‘smart’ insulin that switches on and off based on blood sugar levels, effectively lowering glucose without causing hypos.

What are immunotherapies, and why are people excited about them?
Treatments that target the immune system, known as immunotherapies, are emerging to tackle type 1 diabetes. In this blog, we explain what they are and their potential to make a life-changing differ…
Putting people affected by type 1 diabetes at the heart of research.
The Type 1 Diabetes Grand Challenge brings together scientists and the type 1 community to drive forward progress in areas that matter most to people with type 1.

